Overview
Location
United States, Florida, Miami
Employees
501-1000
Founded date
1993
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 20, 2026 | Soufflé Therapeutics Raises $135 Million Series B Led By Juvia Group To Advance Clinical Pipeline | Soufflé Therapeutics has closed an oversubscribed $135 million Series B financing to advance its lead programs into clinical development and expand its pipeline of cell-specific oligonucleotide therapies. The round was led by Juvia Group an... |
| Oct 19, 2026 | Souffle Therapeutics Nets $135M Series B | BOSTON, MA, Souffle Therapeutics, a leading RNA therapies company aimed at advancing the next generation of therapies designed to help people live healthier lives, announced the close of an oversubscribed $135 million Series B financing le... |
| Oct 16, 2026 | Venture Capital Shifts Focus to Tangible Innovation: Billions Fuel Real-World Tech | Investors globally are funneling hundreds of millions into technologies solving concrete, expensive problems. This week’s funding rounds highlight a clear pivot from abstract promises to deployable, operational results. Construction automat... |
| Oct 14, 2026 | Startup Funding News Today, October 14, 2026: Allara, ICON, Pluto Security, Soufflé Therapeutics, SUNMMIO & More | Today’s funding activity shows investors continuing to pour hundreds of millions of dollars into technologies that solve expensive problems in the physical world. Austin-based ICON secured $200 million to expand its robotic construction sys... |
| Oct 7, 2026 | Matchpoint Therapeutics Nets $150M in Series B | WATERTOWN, MA, Matchpoint Therapeutics announced the successful closing of a $150 million Series B financing co-led by Nextech Invest and Norwest. >> Click here for more funding data on Matchpoint Therapeutics >> To export Matc... |
| Dec 9, 2021 | BB Biotech : «Cancer medicine improves the chances of a cure» | Important information Please read this page for your own protection before continuing as it contains legal provisions regarding the distribution of this information. The information contained on the following pages is exclusively directed a... |
| Oct 22, 2021 | BB Biotech : increases positions in oncology and CNS | Important information Please read this page for your own protection before continuing as it contains legal provisions regarding the distribution of this information. The information contained on the following pages is exclusively directed a... |
| Apr 25, 2021 | BB Biotech : Sector re-valuation used for portfolio investments | Media release of April 23, 2021 Interim report of BB Biotech AG as at March 31, 2021 Successful vaccination campaigns point the way out of the corona crisis - sector re-valuation used for portfolio investments Biotech delivered positive res... |
| Apr 25, 2021 | BB Biotech : publishes interim report | Important information Please read this page for your own protection before continuing as it contains legal provisions regarding the distribution of this information. The information contained on the following pages is exclusively directed a... |
Show more
Reviews 0
FAQ about BB Biotech AG
When was BB Biotech AG founded?
BB Biotech AG was founded in 1993.
What has the press written about BB Biotech AG?
Parsers VC has collected 12 articles mentioning BB Biotech AG, among them “Soufflé Therapeutics Raises $135 Million Series B Led By Juvia Group To Advance Clinical Pipeline” (Oct 20, 2026) and “Souffle Therapeutics Nets $135M Series B” (Oct 19, 2026).
Is BB Biotech AG still active?
Yes, BB Biotech AG is active; its latest activity on Parsers VC dates from Oct 20, 2026.